Oruka Therapeutics Inc. (ORKA)
ORKA trades on Nasdaq in Health Care, Biotechnology: In Vitro & In Vivo Diagnostic Substances. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$78.19
-2.69% on the day
Market cap
$5.2B
Mid cap
Revenue
No annual revenue filed since the period ending 2023-12-31
Net income
No annual revenue filed since the period ending 2023-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ORKA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000907654 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2023-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B5 | 2026-08-28 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-12 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-10 |
| Latest current report CURRENT REPORT | 8-K | 2026-08-24 |
| Latest proxy PROXY STATEMENT | DEFA14A | 2026-04-17 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.5% |
| 1 month | -16.8% |
| 3 months | -7.7% |
| Year to date | +153.0% |
| 1 year | +200.6% |
| From 52-week high | -32.2% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: In Vitro & In Vivo Diagnostic Substances
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| LNTH | Lantheus Holdings Inc. | $100.02 | -0.09% | $6.5B |
| NEOG | Neogen Corporation | $11.73 | -2.25% | $2.6B |
| CLDX | Celldex Therapeutics Inc. | $28.25 | -4.01% | $2.2B |
| NTLA | Intellia Therapeutics Inc. | $11.91 | -5.33% | $1.7B |
| QDEL | QuidelOrtho Corporation | $14.10 | +6.42% | $966.9M |
| ACHV | Achieve Life Sciences Inc. Common Shares | $7.00 | -0.85% | $720.3M |
| IDXX | IDEXX Laboratories Inc. | $520.31 | -0.69% | $41.0B |
| NNNN | Anbio Biotechnology | $4.26 | -3.40% | $613.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier